Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage

Journal of NeuroInterventional Surgery

Volumn 5, Issue 6, 2013, Pages 512-517

  McMahon, Catherine J ^a   Hopkins, Stephen ^a   Vail, Andy ^a   King, Andrew T ^a   Smith, Debi ^a   Illingworth, Karen J ^a   Clark, Simon ^a   Rothwell, Nancy J ^a   Tyrrell, Pippa J ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; COHORT ANALYSIS; DELAYED CEREBRAL ISCHEMIA; DISEASE ASSOCIATION; DISEASE MARKER; DRUG BRAIN LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNE RESPONSE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ANEURYSM; HEMORRHAGE; INFLAMMATION; INFLAMMATORY RESPONSE; SUBARACHNOID;

ADULT; AGED; BLOOD SEDIMENTATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBRAL ANGIOGRAPHY; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; YOUNG ADULT;

EID: 84885363315     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2012-010386     Document Type: Article

References (44)

1. Stein SC, Levine JM, Nagpal S, et al. Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus 2006;21:E2.
2. Ohkuma H, Manabe H, Tanaka M, et al. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621-7. (Pubitemid 30437513)
3. Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-9.
4. Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004;4:2.
5. Osuka K, Suzuki Y, Tanazawa T, et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 1998;140:943-51. (Pubitemid 28474664)
6. Gaetani P, Tartara F, Pignatti P, et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337-42. (Pubitemid 28247128)
7. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001;70:534-7. (Pubitemid 32269696)
8. Schoch B, Regel JP, Wichert M, et al. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery 2007;60:828-36.
9. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001;16:774-80.
10. Mathiesen T, Andersson B, Loftenius A, et al. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993;78:562-7. (Pubitemid 23099464)
11. Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 2004;25:141-7. (Pubitemid 44783371)
12. Sarrafzadeh A, Schlenk F, Gericke C, et al. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2010;13:339-46.
13. Mathiesen T, Edner G, Ulfarsson E, et al. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-Alpha following subarachnoid hemorrhage. J Neurosurg 1997;87:215-20. (Pubitemid 27349105)
14. Greenhalgh AD, Galea J, Denes A, et al. Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection. Br J Pharmacol 2010;160:153-9.
15. McColl BW, Allan SM, Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009;158:1049-61.
16. Hirashima Y, Nakamura S, Endo S, et al. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 1997;22:1249-55. (Pubitemid 27440793)
17. Parkinson D, Stephensen S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol 1984;21:132-4. (Pubitemid 14183422)
18. Spallone A, Acqui M, Pastore FS, et al. Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol 1987;27:253-8. (Pubitemid 17030015)
19. Rothoerl RD, Axmann C, Pina AL, et al. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2006;18:68-72. (Pubitemid 44491162)
20. Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003;139:93-101. (Pubitemid 36694395)
21. Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest 1991;21:479-84.
22. Emsley HC, Smith CJ, Georgiou RF, et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005;76:1366-72. (Pubitemid 41360973)
23. Selvarajah JR, Smith CJ, Hulme S, et al. Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study. Int J Stroke 2011;6:187-94.
24. Beamer NB, Coull BM, Clark WM, et al. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995;37:800-5.
25. Kim JS, Yoon SS, Kim YH, et al. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-7. (Pubitemid 26295905)
26. Perini F, Morra M, Alecci M, et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 2001;22:289-96. (Pubitemid 34071562)
27. Emsley HC, Smith CJ, Gavin CM, et al. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 2007;7:5.
28. Balestrino M, Partinico D, Finocchi C, et al. White blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 1998;7:139-44.
29. Chamorro A, Vila N, Ascaso C, et al. Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke 1995;26:573-6.
30. Andresdottir MB, Sigfusson N, Sigvaldason H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study. Am J Epidemiol 2003;158:844-51. (Pubitemid 37323246)
31. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11. (Pubitemid 28243661)
32. Ni W, Gu YX, Song DL, et al. The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:203-8.
33. Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32:1955-61. (Pubitemid 44833108)
34. Tuna M, Yilmaz DM, Erman T, et al. Effect of neutralization of rat interleukin 6 bioactivity on inducible nitric oxide synthase up-regulation and cerebral ischemic damage. Neurol Res 2009;31:714-20.
35. Rossi E, Biasucci LM, Citterio F, et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002;105:800-3. (Pubitemid 34174918)
36. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-5. (Pubitemid 29211614)
37. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001;32:917-24. (Pubitemid 32285161)
38. Kasius KM, Frijns CJ, Algra A, et al. Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2010;29:576-83.
39. Bain BJ. Some influences on the ESR and the fibrinogen level in healthy subjects. Clin Lab Haematol 1983;5:45-54. (Pubitemid 13119090)
40. Fletcher AP, Alkjaersig N, Davies A, et al. Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 1976;7:337-48.
41. Vergouwen MD, Vermeulen M, Coert BA, et al. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761-70.
42. Fujii Y, Takeuchi S, Sasaki O, et al. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg 1997;86:594-602. (Pubitemid 27138627)
43. Nina P, Schisano G, Chiappetta F, et al. A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with Hunt-Hess grade and outcome. Surg Neurol 2001;55:197-203. (Pubitemid 32453178)
44. Peltonen S, Juvela S, Kaste M, et al. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 1997;87:207-14. (Pubitemid 27349104)